Загрузка...
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
BACKGROUND: Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis in foetal life. Researchers have recently attempted to use anti‐VEGF agents for the treatment of retinopathy of prematurity (ROP), a vasoproliferative disorder. The safety and efficacy of these agents in preterm i...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2018
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491066/ https://ncbi.nlm.nih.gov/pubmed/29308602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009734.pub3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|